Diabetes 51:1218-1225, 2002
© 2002 by the American Diabetes Association, Inc.
Difference in Ischemic Regulation of Vascular Endothelial Growth Factor and Pigment Epithelium--Derived Factor in Brown Norway and Sprague Dawley Rats Contributing to Different Susceptibilities to Retinal Neovascularization
Guoquan Gao1,
Yan Li1,
James Fant1,
Craig E. Crosson1,
S. Patricia Becerra2, and
Jian-xing Ma1
1 Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina
2 Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, Bethesda, Maryland
The present study compared susceptibilities of Sprague Dawley (SD) and Brown Norway (BN) rats with ischemia-induced retinal neovascularization. An exposure to constant hyperoxia followed by normoxia induced significant retinal neovascularization in BN rats but not in SD rats, as demonstrated by fluorescein retinal angiography, measurement of avascular area, and count of preretinal vascular cells. These results indicate a rat strain difference in susceptibility to retinal neovascularization. To understand the molecular basis responsible for the strain difference, we have measured the levels of pigment epithelium-derived factor (PEDF), an angiogenic inhibitor, and vascular endothelial growth factor (VEGF), a major angiogenic stimulator in the retina. The hyperoxia-treated BN rats showed a significant reduction in retinal PEDF, but they showed a substantial increase of VEGF at both the protein and RNA levels, resulting in an increased VEGF-to-PEDF ratio. Hyperoxia-treated SD rats showed changes in PEDF and VEGF levels that were less in magnitude and of shorter duration than in BN rats. In age-matched normal BN and SD rats, however, there was no detectable difference in the basal VEGF-to-PEDF ratio between the strains. These observations support the idea that different regulation of angiogenic inhibitors and stimulators under ischemia are responsible for the differences in susceptibility to ischemia-induced retinal neovascularization in SD and BN rats.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Lu, Y. Zhou, K. Kaufman, R. Mott, and J.-x. Ma
Rat strain-dependent susceptibility to ischemia-induced retinopathy associated with retinal vascular endothelial growth factor regulation
J. Mol. Endocrinol.,
April 1, 2007;
38(4):
423 - 432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. van Wijngaarden, H. M. Brereton, D. J. Coster, and K. A. Williams
Genetic Influences on Susceptibility to Oxygen-Induced Retinopathy
Invest. Ophthalmol. Vis. Sci.,
April 1, 2007;
48(4):
1761 - 1766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. X Zhang, J. J Wang, G. Gao, K. Parke, and J.-x. Ma
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
J. Mol. Endocrinol.,
August 1, 2006;
37(1):
1 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Notari, A. Miller, A. Martinez, J. Amaral, M. Ju, G. Robinson, L. E. H. Smith, and S. P. Becerra
Pigment Epithelium-Derived Factor Is a Substrate for Matrix Metalloproteinase Type 2 and Type 9: Implications for Downregulation in Hypoxia
Invest. Ophthalmol. Vis. Sci.,
August 1, 2005;
46(8):
2736 - 2747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Lang, J. Blackledge, and R. W. Arnold
Is Pacific Race a Retinopathy of Prematurity Risk Factor?
Arch Pediatr Adolesc Med,
August 1, 2005;
159(8):
771 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. van Wijngaarden, D. J. Coster, H. M. Brereton, I. L. Gibbins, and K. A. Williams
Strain-Dependent Differences in Oxygen-Induced Retinopathy in the Inbred Rat
Invest. Ophthalmol. Vis. Sci.,
April 1, 2005;
46(4):
1445 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. X. Zhang, J.-x. Ma, J. Sima, Y. Chen, M. S. Hu, A. Ottlecz, and G. N. Lambrou
Genetic Difference in Susceptibility to the Blood-Retina Barrier Breakdown in Diabetes and Oxygen-Induced Retinopathy
Am. J. Pathol.,
January 1, 2005;
166(1):
313 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Baluk, C. G. Lee, H. Link, E. Ator, A. Haskell, J. A. Elias, and D. M. McDonald
Regulated Angiogenesis and Vascular Regression in Mice Overexpressing Vascular Endothelial Growth Factor in Airways
Am. J. Pathol.,
October 1, 2004;
165(4):
1071 - 1085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, J.-G. Ren, W. L. Cooper, C. E. Hawkins, M. R. Cowan, and P. Y. Tong
Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site
PNAS,
April 27, 2004;
101(17):
6605 - 6610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ohno-Matsui, T. Uetama, T. Yoshida, M. Hayano, T. Itoh, I. Morita, and M. Mochizuki
Reduced Retinal Angiogenesis in MMP-2-Deficient Mice
Invest. Ophthalmol. Vis. Sci.,
December 1, 2003;
44(12):
5370 - 5375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-B. Shui, X. Wang, J. S. Hu, S.-P. Wang, C. M. Garcia, J. D. Potts, Y. Sharma, and D. C. Beebe
Vascular Endothelial Growth Factor Expression and Signaling in the Lens
Invest. Ophthalmol. Vis. Sci.,
September 1, 2003;
44(9):
3911 - 3919.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|